Trials / Completed
CompletedNCT04001192
Exercise in Patients With Post-Concussion Symptoms
Exercise in Patients With Post-Concussion Symptoms - a Pilot Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- St. Olavs Hospital · Academic / Other
- Sex
- All
- Age
- 16 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Physical activity and exercise have traditionally not been much of a focus in treatment of postconcussion symptoms and posttraumatic headache. On the contrary, patients have often got advice to rest until they were free from symptoms. This approach, however, is challenged, and complete rest should probably be discouraged after the first 24-72 hours. Moderate aerobic exercise has been found promising in the early phase after sports-related concussion, and in the treatment of patients with headache. This study is an open pilot-study of guided, home-based exercise in a clinical sample with postconcussion symptoms and posttraumatic headache after mixed-mechanism mild traumatic brain injury and minimal head injuries. The study will result in data about the feasibility and possible effects of exercise as treatment for prolonged postconcussion symptoms and posttraumatic headache.
Conditions
- Craniocerebral Trauma
- Head Injury, Minor
- Postconcussion Syndrome
- Posttraumatic Headache
- Mild Traumatic Brain Injury
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | aerobic exercise program | The intervention is exercise at home, 5-6 days per week during 12 weeks, guided by a schedule that the physiotherapist will design after initial treadmill testing. Exercise intensity is 80-90 % of the heart rate threshold that was identified by the treadmill test. During the 12 weeks program, intensity will be increased according to feedback from the participant. |
Timeline
- Start date
- 2019-02-14
- Primary completion
- 2021-07-08
- Completion
- 2021-07-08
- First posted
- 2019-06-27
- Last updated
- 2022-03-15
Locations
1 site across 1 country: Norway
Source: ClinicalTrials.gov record NCT04001192. Inclusion in this directory is not an endorsement.